A case of Churg-Strauss syndrome in association with leukotriene modifier therapy when oral corticosteroids were withdrawn in an asthmatic patient.
- Author:
Jae Hee CHO
1
;
Hyun Jin KIM
;
Jae Youn MOON
;
Seung Min JANG
;
Hyung Jong KIM
;
Sang Woon BAE
;
Cheol Woo KIM
;
Il Nam SUNWOO
;
Sang Ho CHO
;
Chein Soo HONG
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Churg-Strauss syndrome;
asthma;
leukotriene antagonist
- MeSH:
Adrenal Cortex Hormones*;
Adult;
Asthma;
Churg-Strauss Syndrome*;
Eosinophilia;
Humans;
Rhinitis;
Systemic Vasculitis;
Vasculitis
- From:Journal of Asthma, Allergy and Clinical Immunology
2002;22(2):487-493
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Churg-Strauss syndrome is one of idiopathic, systemic necrotizing vasculitis characterized by a history of asthma or allergic rhinitis, eosinophilia of peripheral blood and variable symptoms of systemic vasculitis. There have been several recent case reports of Churg-Strauss syndrome in association with leukotriene modifier therapy when oral corticosteroids were withdrawn in asthmatic patients. We report a case of a 31-year-old man with steroid-dependent asthma who developed Churg-Strauss syndrome after 9 months of steroid withdrawal period, while he was receiving leukotriene modifier (Pranlukast).
